1. Clinical characteristics and outcome of hospitalized elderly patients with COVID- 19 after vaccine failure.
- Author
-
Díaz-Menéndez, M., de la Calle-Prieto, F., Montejano, R., Arsuaga, M., Jiménez-González, M., Pérez-Blanco, V., Marcelo, C., Vásquez-Manau, J, Lázaro, F., and Arribas, J.R.
- Subjects
- *
OLDER patients , *HOSPITAL patients , *BREAKTHROUGH infections , *TREATMENT effectiveness , *COVID-19 treatment , *COVID-19 vaccines - Abstract
We described clinical characteristics and outcome of 160 patients over 65 years (01 September to 31 August 2021) who had a first positive SARS-CoV-2 PCR- test more than 14 days after full vaccination and were hospitalized with COVID-19. Median age of included patients was 84 years, 61.2% were over 80 years; 50.6% were male and most (82.5%) has at least one comorbidity. Up to 84% received specific treatment against COVID-19, including 76.9% low-flow oxygen therapy. We found that overall mortality was 25.6% and 30.6% in those older than 80 years. A higher mortality was significantly associated with older age and treatment with tocilizumab. Our data showed that although COVID-19 vaccines continue protecting elderly patients against hospitalization and death and might improve the prognosis after hospitalization in patients with breakthrough infections, mortality in this population -especially in those older than 80 years- remains very high. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF